ScanVacc Overview

  • Founded
  • 1997
  • Status
  • Private
  • Employees
  • 3
  • Latest Deal Type
  • Undetermined

ScanVacc General Information


Developer of pharmaceuticals for fish farming. The company focuses on the development and sale of fish health products such as vaccines and stress reducing drugs for fish farming.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Formerly VC-backed
Primary Industry
Other Healthcare
Other Industries
Drug Discovery
Primary Office
  • Jerpeveien 8
  • 3243 Kodal
  • Norway
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

ScanVacc Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Undetermined 01-Jan-2009 Completed
1. Early Stage VC Completed
To view ScanVacc’s complete valuation and funding history, request access »

ScanVacc Executive Team (3)

Name Title Board Seat Contact Info
Jon Erdal Ph.D Manager Product Development
Lars Speilberg Project Manager
Ole Kaurstad Managing Director
To view ScanVacc’s complete executive team members history, request access »

ScanVacc Signals

Growth Rate

0.80% Weekly
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers


Similarweb Unique Visitors


Majestic Referring Domains


PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial